Cargando…

Inflammatory bowel disease (IBD)-like disease in a case of a 33-year old man with glycogenosis 1b

BACKGROUND: Inflammatory bowel disease (IBD)-like conditions in glycogen storage disease (GSD) type Ib have been predominantly described in children. Signs and symptoms of GSD type Ib are hypoglycemia, pancytopenia and hepatosplenomegaly. Based on few published cases, there is evidence that granuloc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Volz, Magdalena Sarah, Nassir, Mani, Treese, Christoph, von Winterfeld, Moritz, Plöckinger, Ursula, Epple, Hans-Jörg, Siegmund, Britta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394407/ https://www.ncbi.nlm.nih.gov/pubmed/25881301 http://dx.doi.org/10.1186/s12876-015-0271-9

Ejemplares similares

Hepatic Glycogenosis: An Underdiagnosed Entity?
por: Garcês Soares, Sofia, et al.
Publicado: (2022)

International Perspectives on Management of Inflammatory Bowel Disease: Opinion Differences and Similarities Between Patients and Physicians From the IBD GAPPS Survey
por: Rubin, David T, et al.
Publicado: (2021)

Editorial: Immune-Epithelial Crosstalk in Inflammatory Bowel Diseases and Mucosal Wound Healing
por: Leppkes, Moritz, et al.
Publicado: (2018)

Deciphering the vedolizumab dosing conundrum in IBD: when less is more
por: Adolph, Timon Erik, et al.
Publicado: (2022)

Hereditary Diffuse Gastric Cancer—Update Based on the Current Consort Recommendations
por: Treese, Christoph, et al.
Publicado: (2022)

Non-muscle involvement in late-onset Glycogenosis II
por: FILOSTO, MASSIMILIANO, et al.
Publicado: (2013)

ANTHROPOMETRIC AND DIETARY ASSESSMENT OF PATIENTS WITH GLYCOGENOSIS TYPE I
por: Jorge, Natália Bauab, et al.
Publicado: (2021)

Future of Endoscopy in Inflammatory Bowel Diseases (IBDs)
por: Agrawal, Laksh S, et al.
Publicado: (2022)

Helminth Lessons in Inflammatory Bowel Diseases (IBD)
por: Atagozli, Tyler, et al.
Publicado: (2023)

Bridges to excellence quality indicators in inflammatory bowel disease (IBD): differences between IBD and non-IBD gastroenterologists
por: Bilal, Mohammad, et al.
Publicado: (2017)

COVID-19—from mucosal immunology to IBD patients
por: Weidinger, Carl, et al.
Publicado: (2021)

Epithelial RAC1 niches in IBD: from barrier integrity to cytoskeletal plasticity
por: Haag, Lea-Maxie, et al.
Publicado: (2023)

The Multifaceted Role of the Inflammasome in Inflammatory Bowel Diseases
por: Lissner, Donata, et al.
Publicado: (2011)

Pregnancy in Pompe disease
por: Plöckinger, Ursula
Publicado: (2013)

Janus Kinase inhibitors in the New Treatment Paradigms of Inflammatory Bowel Disease
por: Siegmund, Britta
Publicado: (2020)

S3.2 The role of Patients Association (Italian Glycogenosis Association)
por: Martino, L.
Publicado: (2011)

Validation of the ‘Inflammatory Bowel Disease—Distribution, Chronicity, Activity [IBD-DCA] Score’ for Ulcerative Colitis and Crohn´s Disease
por: Lang-Schwarz, Corinna, et al.
Publicado: (2021)

Pulmonary Interstitial Glycogenosis: An Unrecognized Etiology of Persistent Pulmonary Hypertension of the Newborn in Congenital Heart Disease?
por: Radman, Monique R., et al.
Publicado: (2012)

Satellite cells fail to contribute to muscle repair but are functional in Pompe disease (glycogenosis type II)
por: Lagalice, Lydie, et al.
Publicado: (2018)

Controlled drug release for inflammatory bowel disease (IBD)
por: Asha, D, et al.
Publicado: (2020)

COVID-19 Vaccination in Inflammatory Bowel Disease (IBD)
por: Kubas, Aleksandra, et al.
Publicado: (2022)

Novel Therapies and Approaches to Inflammatory Bowel Disease (IBD)
por: Furfaro, Federica, et al.
Publicado: (2022)

Nutritional Assessment in Inflammatory Bowel Disease (IBD)—Development of the Groningen IBD Nutritional Questionnaires (GINQ)
por: Peters, Vera, et al.
Publicado: (2019)

Endoscopic stricturotomy in the treatment of anastomotic strictures in inflammatory bowel disease (IBD) and non-IBD patients
por: Zhang, Long-Juan, et al.
Publicado: (2019)

Improving the care of inflammatory bowel disease (IBD) patients: perspectives and strategies for IBD center management
por: Park, Jihye, et al.
Publicado: (2021)

Comparative Transcriptomics of IBD Patients Indicates Induction of Type 2 Immunity Irrespective of the Disease Ideotype
por: Gonzalez Acera, Miguel, et al.
Publicado: (2021)

Inflammatory bowel disease (IBD)-disk accurately predicts the daily life burden and parallels disease activity in patients with IBD
por: Singh, Arshdeep, et al.
Publicado: (2023)

Glycogenosis is common in nonalcoholic fatty liver disease and is independently associated with ballooning, but lower steatosis and lower fibrosis
por: Allende, Daniela S, et al.
Publicado: (2021)

Hepatic glycogenosis in type 1 diabetes mellitus mimicking Mauriac syndrome
por: Jung, In Ah, et al.
Publicado: (2015)

Personalizing Treatment in IBD: Hype or Reality in 2020? Can We Predict Response to Anti-TNF?
por: Atreya, Raja, et al.
Publicado: (2020)

Thromboembolic tendency (TE) in IBD (inflammatory bowel disease) patients
por: Canero, A, et al.
Publicado: (2010)

The Involvement of Immune Semaphorins in the Pathogenesis of Inflammatory Bowel Diseases (IBDs)
por: Vadasz, Zahava, et al.
Publicado: (2015)

Improving pediatric Inflammatory Bowel Disease (IBD) follow-up
por: Dykes, Dana, et al.
Publicado: (2016)

The Impact of Inflammatory Bowel Disease in Canada 2018: IBD in Seniors
por: Nguyen, Geoffrey C, et al.
Publicado: (2019)

The 2023 Impact of Inflammatory Bowel Disease in Canada: Epidemiology of IBD
por: Coward, Stephanie, et al.
Publicado: (2023)

The 2023 Impact of Inflammatory Bowel Disease in Canada: Cancer and IBD
por: Murthy, Sanjay K, et al.
Publicado: (2023)

Costs of Healthcare for Children with Inflammatory Bowel Diseases (IBD) in Poland
por: Markiewicz-Łoskot, Grażyna, et al.
Publicado: (2023)

Frequency of Positive Familial Criteria in Patients with Adenocarcinoma of the Esophageal-Gastric Junction and Stomach: First Prospective Data in a Caucasian Cohort †
por: Schölzchen, Jan, et al.
Publicado: (2022)

Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome
por: Khan, Israr, et al.
Publicado: (2019)

From bowel inflammation to the bone and joints: musculoskeletal examination in inflammatory bowel disease (IBD)
por: Tavassoli, Samane, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7kv8kgbl73o2aos0bhs3jigqul